Clinical Trial

Outcomes of Embryos Created From Abnormally Fertilized Oocytes

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to retrospectively analyze data from multiple clinics in a fertility network on embryos that were created from abnormally fertilized oocytes (AFO) including the rate of transfers and any clinical outcomes in order to inform providers in their decision making regarding AFOs.
Trial Details
NCT Number NCT07666243
Lead Sponsor Inception Fertility Research Institute, LLC
Collaborators: Igenomix
Conditions Abnormal Fertilization, Infertility
Enrollment 92 participants
Start Date 2026-06
Primary Completion 2027-06 (estimated)
Study Completion 2027-06 (estimated)
Updated on ClinicalTrials.gov 2026-06-24